Celgene BMS Industry Symposium

Cellular therapies: perspectives for practice

Saturday, May 8, 2021 – 12:30-13:45 CEST

Pr Paul Richardson
Boston, USA

Pr Mohamad Mohty
Paris, France

Pr Xavier Leleu
Poitiers, France

Dr Salomon Manier
Lille, France

Pr Maria-Victoria Mateos
Salamanca, Spain

AGENDA:
Chair: Pr Mohamad Mohty (Paris, France)

12:30-12:50 Controversies on key challenges in multiple myeloma management
Pr Paul Richardson (Boston, USA) and Pr Mohamad Mohty (Paris, France)
12:50-13:15 Multiple myeloma management: optimizing current therapies, preparing for what is new?
Pr Xavier Leleu (Poitiers, France) and Dr Salomon Manier (Lille, France)
13:15-13:35 Relapsed Myeloma: how to integrate cellular therapies in practice?
Pr Maria-Victoria Mateos (Salamanca, Spain)
13:35-13:45 Q&A and discussion
All faculty, moderated by Pr Mohamad Mohty

Bristol-Myers Squibb uses computer files that might include personal data about healthcare professionals. In accordance with the General Data Protection Regulation n°2016/679 of 27 April 2016 and the Data Protection Act n°78-17 of 6 January 1978, modified, each healthcare professional may request access to such data, as well as to receive it, object to its use or restrict the processing of data, and request that it be corrected, completed and/or deleted. If you wish to exercise your rights concerning data privacy, or for any queries, please contact the Data Protection Officer of Bristol-Myers Squibb, who can be reached at EUDPO@BMS.com. Bristol-Myers Squibb is subject to applicable laws related to the collection and reporting of any payments or transfers of value to healthcare providers, healthcare organizations and patient organizations. Your attendance at this meeting implies that you agree and will cooperate with Bristol-Myers Squibb in its compliance with applicable financial transparency requirements.

PDF Program